Medipharm Labs Financials
| MEDIF Stock | USD 0.05 0.0006 1.33% |
With this module, you can analyze Medipharm financials for your investing period. You should be able to track the changes in Medipharm Labs individual financial statements over time to develop the understanding of its risk, liquidity, profitability, or other critical and vital indicators.
Medipharm |
The data published in Medipharm Labs' official financial statements typically reflect Medipharm Labs' business processes, product offerings, services, and other fundamental events. However, there are additional fundamental indicators that are easier to understand and visualize along the underlying realities that are driving Medipharm Labs' quantitative information. For example, before you start analyzing numbers published by Medipharm accountants, it's essential to understand Medipharm Labs' liquidity, profitability, and earnings quality within the context of the Healthcare space in which it operates.
Medipharm Labs Stock Summary
Medipharm Labs competes with Flora Growth, Bionoid Pharma, and C21 Investments. MediPharm Labs Corp., a pharmaceutical company, produces and sells pharmaceutical-quality cannabis oil and concentrates, and advanced derivative products in Canada, Australia, Germany, and internationally. MediPharm Labs Corp. was founded in 2015 and is headquartered in Barrie, Canada. MEDIPHARM LABS is traded on OTC Exchange in the United States.| Instrument | USA OTC Stock View All |
| Exchange | OTCQX Exchange |
| ISIN | CA58504D1006 |
| Business Address | 151 John Street, |
| Sector | Healthcare |
| Industry | Drug Manufacturers—Specialty & Generic |
| Benchmark | Dow Jones Industrial |
| Website | www.medipharmlabs.com |
| Phone | 705 719 7425 |
| Currency | USD - US Dollar |
Medipharm Labs Key Financial Ratios
There are many critical financial ratios that Medipharm Labs' investors are exposed to on a daily basis, but they are usually grouped into few meaningful categories from each financial statement that Medipharm Labs Corp reports annually and quarterly.| Return On Equity | -0.57 | |||
| Return On Asset | -0.24 | |||
| Number Of Employees | 190 | |||
| Beta | 1.15 | |||
| Z Score | 6.6 |
Medipharm Financial Ratios Relationships
Comparative valuation techniques use various fundamental indicators to help in determining Medipharm Labs's current stock value. Our valuation model uses many indicators to compare Medipharm Labs value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Medipharm Labs competition to find correlations between indicators driving Medipharm Labs's intrinsic value. More Info.Medipharm Labs Corp is rated below average in return on equity category among its peers. It is rated below average in return on asset category among its peers . The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Medipharm Labs' earnings, one of the primary drivers of an investment's value.Medipharm Labs Corp Systematic Risk
Medipharm Labs' systematic risk plays a vital role in portfolio allocation when considering its stock to be added to a well-diversified portfolio. Medipharm Labs volatility which cannot be eliminated through diversification, requires returns over the risk-free rate. Over the long run, a well-diversified portfolio provides returns that match its exposure to systematic risk. In this case, investors face a trade-off between expected returns and systematic risk and, therefore, can only reduce a portfolio's exposure to systematic risk by sacrificing expected returns on the portfolio.
The function did not generate any output. Please change time horizon or modify your input parameters. The output start index for this execution was one with a total number of output elements of sixty. The Beta measures systematic risk based on how returns on Medipharm Labs Corp correlated with the market. If Beta is less than 0 Medipharm Labs generally moves in the opposite direction as compared to the market. If Medipharm Labs Beta is about zero movement of price series is uncorrelated with the movement of the benchmark. if Beta is between zero and one Medipharm Labs Corp is generally moves in the same direction as, but less than the movement of the market. For Beta = 1 movement of Medipharm Labs is generally in the same direction as the market. If Beta > 1 Medipharm Labs moves generally in the same direction as, but more than the movement of the benchmark.
Medipharm Labs December 18, 2024 Opportunity Range
Along with financial statement analysis, the daily predictive indicators of Medipharm Labs help investors to analyze its daily demand and supply, volume, patterns, and price swings to determine the real value of Medipharm Labs Corp. We use our internally-developed statistical techniques to arrive at the intrinsic value of Medipharm Labs Corp based on widely used predictive technical indicators. In general, we focus on analyzing Medipharm OTC Stock price patterns and their correlations with different microeconomic environment and drivers. We also apply predictive analytics to build Medipharm Labs's daily price indicators and compare them against related drivers.
| Downside Deviation | 3.83 | |||
| Information Ratio | 0.0054 | |||
| Maximum Drawdown | 19.11 | |||
| Value At Risk | (6.00) | |||
| Potential Upside | 6.56 |
Complementary Tools for Medipharm OTC Stock analysis
When running Medipharm Labs' price analysis, check to measure Medipharm Labs' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Medipharm Labs is operating at the current time. Most of Medipharm Labs' value examination focuses on studying past and present price action to predict the probability of Medipharm Labs' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Medipharm Labs' price. Additionally, you may evaluate how the addition of Medipharm Labs to your portfolios can decrease your overall portfolio volatility.
| Transaction History View history of all your transactions and understand their impact on performance | |
| Stock Screener Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook. |